CCL Featured Stories, Homepage Featured Stories, Special Communication
December 2022: Changes to Acceptable Specimen Containers for Azole Anti-Fungal Therapeutic Drug Monitoring
Special Communication
All changes are effective December 20, 2022.
Plasma collected in Green Lithium Heparin Tubes will no longer be accepted for azole anti-fungal therapeutic drug monitoring tests.
Please collect samples for Azole Anti-Fungal Therapeutic Drug Monitoring tests in Red (serum) No Additive Tubes, centrifuge, and transfer the serum to an aliquot tube.
Updated Specimen Requirements
Specimen Type:
Serum
Volume:
0.5 mL
Collection Container:
Red (Serum) No Additive Tube
Transport Temperature:
Refrigerated
Do not use gel separator tubes.
Any additional information will be included in a future Technical Update.
If you have any questions about these changes, please contact Client Services for assistance.
